Акушерство и Гинекология Санкт-Петербурга. 2017; : 84-86
Современный взгляд на этиопатогенез аномальных маточных кровотечений
Аннотация
В обзорной статье изложен современный взгляд на этиопатогенез аномальных маточных кровотечений, систему гемостаза, изменения в эндометрии при данной патологии.
Список литературы
1. Livingstone M., Fraser I.S. Mechanisms of abnormal uterine bleeding. Human Reproduction Update. 2002; 8 (1): 60–67.
2. Яглов В.В. Маточные кровотечения и гемостаз. Consilium medicum. Гинекология. 2007; 9 (6): 24–28.
3. Nicholson W.K., Ellison S.A., Grason H., Powe N.R. Pattern of ambulatory care use for gynecologic conditions: a national study. Am. J. Obstet. Gynecol. 2001; 184 (4): 523–530. DOI: 10.1067/mob.2001.111795.
4. Руководство по эндокринной гинекологии / под ред. Вихляевой. Е.М. М.: Мед. информ. агентство; 2000. 768.
5. Philipp C.S., Faiz A., Dowling N., Dilley A., Michaels L.A., Ayers C. et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet. Gynecol. 2005; 105 (1): 61–66. DOI: 10.1097/01.AOG.0000148889.15061.fb.
6. Kouides P.A. Evaluation of abnormal bleeding in women. Curr. Hematol. Rep. 2002; 1 (1): 11–18.
7. Bouma B.N., Van Mourik J.A. Unraveling the mystery of von Willebrand factor. Journal of Thrombosis and Haemostasis. 2006; 4 (3): 489–495. DOI: 10.1111/j.1538-7836.2006.01813.x.
8. Дикушина Е.А. Гемореологические нарушения и их коррекция у больных с ювенильными маточными кровотечениями: автореф. дис. ... канд. мед. наук / Е.А. Дикушина; Росс. гос. мед. ун-т. Москва; 1996.
9. Furie B., Furie B.C. Thrombus formation in vivo. J. Clin. Investig. 2005; 115 (12): 3355–3362. DOI: 10.1172/JCI26987.
10. Koh S.C., Prasad R.N., Fong Y.F. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle. Clin. Appl. Thromb. Hemost. 2005; 11 (3): 295–301.
11. Schatz F., Krikun G., Caze R., Rahman M., Lockwood C.J. Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis. Steroids. 2003; 68 (10–13): 849–860.
12. Lockwood C.J., Krikun G., Rahman M., Caze R., Buchwalder L., Schatz F. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin. Thromb. Hemost. 2007; 33 (1): 111–117. DOI: 10.1055/s-2006-958469.
13. Lumsden M.A., McGavigan J. Menstruation and menstrual disorder. Gynaecology. 2002; 31 (7): 462–476.
14. Munro M.G1., Lukes A.S. Abnormal Uterine Bleeding and Underlying Hemostatic Disorders Consensus Group. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process. Fertility and Sterility. 2005; 84 (5): 1335–1337. DOI: 10.1016/j.fertnstert.2005.08.008.
15. Paper R. Gynecological complications in women with bleeding disorders. Haemophilia. 2000; 6 (1): 28–33.
16. Светлаков А.В., Яманова М.В., Егорова А.Б., Михуткина С.В. Молекулярнобиологические аспекты имплантации у человека и животных. Проблемы репродукции. 2002; 2: 16–24.
17. Lukes A.S., Perry S., Ortel T.L. Von Willebrand’s disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system. Obstet. Gynecol. 2005; 105 (5, Pt. 2): 1223–1226. DOI: 10.1097/01.AOG.0000157758.94890.59.
18. Edlund M., Blomback M., He S. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin. Blood Coagul. Fibrinolysis. 2003; 14 (6): 593–598. DOI: 10.1097/01.mbc.0000061343.72909.8a.
Obstetrics and Gynaecology of Saint-Petersburg. 2017; : 84-86
The modern view on the pathogenesis of abnormal uterine bleedings
Abstract
In a review article describes the modern view on the etiopathogenesis of abnormal uterine bleeding, hemostasis system, changes in the endometrium in this pathology.
References
1. Livingstone M., Fraser I.S. Mechanisms of abnormal uterine bleeding. Human Reproduction Update. 2002; 8 (1): 60–67.
2. Yaglov V.V. Matochnye krovotecheniya i gemostaz. Consilium medicum. Ginekologiya. 2007; 9 (6): 24–28.
3. Nicholson W.K., Ellison S.A., Grason H., Powe N.R. Pattern of ambulatory care use for gynecologic conditions: a national study. Am. J. Obstet. Gynecol. 2001; 184 (4): 523–530. DOI: 10.1067/mob.2001.111795.
4. Rukovodstvo po endokrinnoi ginekologii / pod red. Vikhlyaevoi. E.M. M.: Med. inform. agentstvo; 2000. 768.
5. Philipp C.S., Faiz A., Dowling N., Dilley A., Michaels L.A., Ayers C. et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet. Gynecol. 2005; 105 (1): 61–66. DOI: 10.1097/01.AOG.0000148889.15061.fb.
6. Kouides P.A. Evaluation of abnormal bleeding in women. Curr. Hematol. Rep. 2002; 1 (1): 11–18.
7. Bouma B.N., Van Mourik J.A. Unraveling the mystery of von Willebrand factor. Journal of Thrombosis and Haemostasis. 2006; 4 (3): 489–495. DOI: 10.1111/j.1538-7836.2006.01813.x.
8. Dikushina E.A. Gemoreologicheskie narusheniya i ikh korrektsiya u bol'nykh s yuvenil'nymi matochnymi krovotecheniyami: avtoref. dis. ... kand. med. nauk / E.A. Dikushina; Ross. gos. med. un-t. Moskva; 1996.
9. Furie B., Furie B.C. Thrombus formation in vivo. J. Clin. Investig. 2005; 115 (12): 3355–3362. DOI: 10.1172/JCI26987.
10. Koh S.C., Prasad R.N., Fong Y.F. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle. Clin. Appl. Thromb. Hemost. 2005; 11 (3): 295–301.
11. Schatz F., Krikun G., Caze R., Rahman M., Lockwood C.J. Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis. Steroids. 2003; 68 (10–13): 849–860.
12. Lockwood C.J., Krikun G., Rahman M., Caze R., Buchwalder L., Schatz F. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin. Thromb. Hemost. 2007; 33 (1): 111–117. DOI: 10.1055/s-2006-958469.
13. Lumsden M.A., McGavigan J. Menstruation and menstrual disorder. Gynaecology. 2002; 31 (7): 462–476.
14. Munro M.G1., Lukes A.S. Abnormal Uterine Bleeding and Underlying Hemostatic Disorders Consensus Group. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process. Fertility and Sterility. 2005; 84 (5): 1335–1337. DOI: 10.1016/j.fertnstert.2005.08.008.
15. Paper R. Gynecological complications in women with bleeding disorders. Haemophilia. 2000; 6 (1): 28–33.
16. Svetlakov A.V., Yamanova M.V., Egorova A.B., Mikhutkina S.V. Molekulyarnobiologicheskie aspekty implantatsii u cheloveka i zhivotnykh. Problemy reproduktsii. 2002; 2: 16–24.
17. Lukes A.S., Perry S., Ortel T.L. Von Willebrand’s disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system. Obstet. Gynecol. 2005; 105 (5, Pt. 2): 1223–1226. DOI: 10.1097/01.AOG.0000157758.94890.59.
18. Edlund M., Blomback M., He S. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin. Blood Coagul. Fibrinolysis. 2003; 14 (6): 593–598. DOI: 10.1097/01.mbc.0000061343.72909.8a.
